Business/press release/2026-09-28

UltraSight secures $24 million in Series B2 funding for AI-guided cardiac ultrasound

UltraSight announced it has raised $24 million in a Series B2 funding round. The company states this capital will be used to expand its AI-guided cardiac ultrasound technology. This information is primarily based on the company's own announcement, as reported by both DOTmed and MassDevice.

2 articles from 2 outlets covered this story. The underlying claim is sourced from a press release.

What do all outlets agree on?

2 outlets covered “UltraSight secures $24 million in Series B2 funding for AI-guided cardiac ultrasound”. All of them report the following:

  • UltraSight raised $24 million
  • Funding is for Series B2 round
  • Funds will be used to scale AI-guided cardiac ultrasound technology

Which outlets covered this?

All 2 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.

What related stories are there?

Get the week in AI in one email

What happened, which outlets reported it, and where their coverage differed. One issue a week.

The first issue hasn’t gone out yet. Subscribe and it’s the one you’ll get.

We’ll send the digest and nothing else. One-click unsubscribe. Privacy.